Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
IPP-204106
print preview
bookmark
share with colleague
General Information
Company
ImmuPharma plc
Description
Nucleolin antagonist
Molecular Target
Nucleolin
Mechanism of Action
Binds nucleolin
Latest Stage of Development
Phase I/II
Indication
Cancer
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information